GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cambridge Nutritional Sciences PLC (LSE:CNSL) » Definitions » Asset Turnover

Cambridge Nutritional Sciences (LSE:CNSL) Asset Turnover : 0.30 (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cambridge Nutritional Sciences Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Cambridge Nutritional Sciences's Revenue for the six months ended in Sep. 2024 was £4.13 Mil. Cambridge Nutritional Sciences's Total Assets for the quarter that ended in Sep. 2024 was £13.70 Mil. Therefore, Cambridge Nutritional Sciences's Asset Turnover for the quarter that ended in Sep. 2024 was 0.30.

Asset Turnover is linked to ROE % through Du Pont Formula. Cambridge Nutritional Sciences's annualized ROE % for the quarter that ended in Sep. 2024 was -4.08%. It is also linked to ROA % through Du Pont Formula. Cambridge Nutritional Sciences's annualized ROA % for the quarter that ended in Sep. 2024 was -2.86%.


Cambridge Nutritional Sciences Asset Turnover Historical Data

The historical data trend for Cambridge Nutritional Sciences's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cambridge Nutritional Sciences Asset Turnover Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.28 0.36 0.47 0.69

Cambridge Nutritional Sciences Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.26 0.35 0.35 0.30

Competitive Comparison of Cambridge Nutritional Sciences's Asset Turnover

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's Asset Turnover falls into.


;
;

Cambridge Nutritional Sciences Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Cambridge Nutritional Sciences's Asset Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=9.774/( (14.405+13.894)/ 2 )
=9.774/14.1495
=0.69

Cambridge Nutritional Sciences's Asset Turnover for the quarter that ended in Sep. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=4.134/( (13.894+13.504)/ 2 )
=4.134/13.699
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Cambridge Nutritional Sciences  (LSE:CNSL) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Cambridge Nutritional Sciences's annulized ROE % for the quarter that ended in Sep. 2024 is

ROE %**(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=-0.392/9.611
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.392 / 8.268)*(8.268 / 13.699)*(13.699/ 9.611)
=Net Margin %*Asset Turnover*Equity Multiplier
=-4.74 %*0.6035*1.4253
=ROA %*Equity Multiplier
=-2.86 %*1.4253
=-4.08 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Cambridge Nutritional Sciences's annulized ROA % for the quarter that ended in Sep. 2024 is

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=-0.392/13.699
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.392 / 8.268)*(8.268 / 13.699)
=Net Margin %*Asset Turnover
=-4.74 %*0.6035
=-2.86 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Cambridge Nutritional Sciences Asset Turnover Related Terms

Thank you for viewing the detailed overview of Cambridge Nutritional Sciences's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Cambridge Nutritional Sciences Business Description

Traded in Other Exchanges
N/A
Address
One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. It also provides clinical analysis to the general public, clinics, and health professionals as well as supplying the point-of-care Food Detective test. The Corporate segment consists of centralised corporate costs which are not allocated to the trading activities of the group. The company generates the majority of its revenue from the Health and Nutrition segment.